JP Morgan Chase’s Electra Therapeutics, Inc. Common stock ETRA Stock Holding History

JP Morgan Chase’s Portfolio ETRA Stock Details ETRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$23.8M	Buy	+2,095,670	New	+$25.8M	﹤0.01%	2057

Other funds holding ETRA

EQT Fund Management Luxembourg $947M AUM 19.95% 1-Year Est. Return

Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Aster Capital Management Dubai, United Arab Emirates $275M AUM 18.46% 1-Year Est. Return

JP Morgan Chase's ETRA Position: Q3 2026 in Review

JP Morgan Chase opened a new position in Electra Therapeutics, Inc. Common stock (ETRA) in Q3 2026: 2,095,670 shares worth $23.8M. The stake represents ﹤0.01% of the portfolio and ranks #2057 among its holdings.

12 funds tracked by Wall St. Rank hold ETRA as of Q3 2026.

JP Morgan Chase held 2,095,670 shares of Electra Therapeutics, Inc. Common stock worth $23.8M as of Q3 2026.
Electra Therapeutics, Inc. Common stock was a new JP Morgan Chase position in Q3 2026.
Electra Therapeutics, Inc. Common stock made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #2057 holding.
12 funds tracked by Wall St. Rank held Electra Therapeutics, Inc. Common stock as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.